@reflexion.com
SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
PNG
About
Description
RefleXion Medical is a dynamic and innovative brand with a powerful mission to revolutionize cancer care. Combining medical physics, nuclear medicine, and radiotherapy, RefleXion is challenging the traditional approach to cancer treatment. With a relentless desire to beat cancer, RefleXion aims to reveal the disease as never before and make a difference for patients everywhere.
Their groundbreaking technology, SCINTIX™ Therapy, is at the forefront of their offerings. By combining biotargeting with radiation, RefleXion enables systemic reach for radiotherapy for patients at any stage of cancer. This revolutionary approach was conceptualized in 2007 when co-founders Akshay Nanduri and Sam Mazin envisioned harnessing cancer's own biology to treat multiple tumors simultaneously.
Driven by their vision and supported by blue-chip investors and premier investment firms, RefleXion has raised nearly $400 million to date. They have also received FDA clearance for their technology and garnered recognition in the medical community. With RefleXion, localized cancer treatment is seeing significant innovation, offering new hope for patients in their fight against cancer
Company Type
Privately Held
Company Size
201-500
Year Founded
2009
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online